Medtech

One day after Abbott secured Emergency Use Authorization for its $5 coronavirus test, the White House awarded the company a $750 million contract to deliver 150 million Abbott BinaxNOW COVID-19 Ag Card Point of Care (POC) SARS-CoV-2 diagnostic tests.
The study concludes that they can detect almost 50% of COVID-19 cases a day before enrollees in the study reported the onset of symptoms, and they do so with 70% specificity.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 10, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 8, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 6, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 1, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 29, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 26, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 24, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 15, 2020.
PRESS RELEASES